Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Sorrento Announces Drilling Contract & Receives Permit to Drill Bottom Brook Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Protara Therapeutics Inc TARA

Healthcare Biotechnology
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company’s lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous... see more

Current News (NDAQ:TARA)

Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones

GlobeNewswire 3 days ago

Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support

GlobeNewswire 8 days ago

Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 8 days ago

Protara Therapeutics Receives Both FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Patients with Lymphatic Malformations

GlobeNewswire 10 days ago

Protara Announces Closing of $75 Million Public Offering

GlobeNewswire December 8, 2025

Protara Announces Pricing of $75 Million Public Offering

GlobeNewswire December 4, 2025

Protara Announces Proposed Public Offering

GlobeNewswire December 4, 2025

Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients

GlobeNewswire December 3, 2025

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025

GlobeNewswire December 1, 2025
View More News ››

Opinion & Analysis (NDAQ:TARA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TARA)

Protara vs Theralase

to evaluate whether Theralase or Protara Therapeutics would generate the most returns, we need to consider several financial and...
leste3221 - December 5, 2024

Protara Therapeutics, Inc. (NASDAQ:TARA): A Promising Biopha

http://beyondspx.com/2024/08/01/protara-therapeutics-inc-nasdaqtara-a-promising-biopharmaceutical-company-advancing-transformative...
MikeTester - August 2, 2024

still holding this stock

for a long time for me,merger completed,so it's time to go up again in share price,should be an easy triple for shareholders glta.
coolfooldumbguy - January 9, 2020

it's a buy today for me

at lunchtime for .57 cents per share,so glta.
coolfooldumbguy - May 22, 2019
View more Bullboard ››

Osisko Development Corp.

Osisko Development Corp.

Osisko Development Corp. is a continental North American gold development company focused on past-producing mining camps ...
View More »

Podcasts